+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
Hemophilia Market Report 2025 - Product Thumbnail Image

Hemophilia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Diabetic Neuropathy Market Report 2025 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
From
From
From
Pharmaceutical Market in Denmark 2025-2029 - Product Thumbnail Image

Pharmaceutical Market in Denmark 2025-2029

  • Report
  • March 2025
  • 186 Pages
  • Denmark
From
Disposable Syringes Market - Global Forecast 2026-2032 - Product Thumbnail Image

Disposable Syringes Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 198 Pages
  • Global
From
Hepatitis Therapeutics Market Report 2025 - Product Thumbnail Image

Hepatitis Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Loading Indicator